Loading...

Elixinol Wellness Limited

EXL.AXASX
Healthcare
Drug Manufacturers - Specialty & Generic
A$0.01
A$-0.00(-13.33%)

Elixinol Wellness Limited EXL.AX Peers

See (EXL.AX) competitors and their performances in Stock Market.

Peer Comparison Table: Drug Manufacturers - Specialty & Generic Industry

Detailed financial metrics including price, market cap, P/E ratio, and more.

SymbolPriceChange %Market CapP/E RatioEPSDividend Yield
EXL.AXA$0.01-13.33%3M-1.30-A$0.01N/A
CAU.AXA$0.54N/A300.5M-16.88-A$0.03N/A
AFP.AXA$2.41-2.03%252.7M24.10A$0.10+0.61%
PBP.AXA$2.98-0.33%242.3M29.80A$0.10N/A
LV1.AXA$0.92N/A144.1M3.05A$0.30N/A
VLS.AXA$2.13+3.40%116M12.53A$0.17+4.69%
IHL.AXA$0.04-10.87%65.1M-0.03-A$1.30N/A
MVP.AXA$0.55N/A62M-1.62-A$0.34N/A
ANP.AXA$0.06-4.92%52.3M-2.90-A$0.02N/A
VIT.AXA$0.07-1.52%43M6.50A$0.01N/A
Showing 1 to 10 of 29 results
1

Stock Comparison

Select a stock to compare (requires JavaScript). Showing default comparison.

EXL.AX vs CAU.AX Comparison

EXL.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EXL.AX stands at 3M. In comparison, CAU.AX has a market cap of 300.5M. Regarding current trading prices, EXL.AX is priced at A$0.01, while CAU.AX trades at A$0.54.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EXL.AX currently has a P/E ratio of -1.30, whereas CAU.AX's P/E ratio is -16.88. In terms of profitability, EXL.AX's ROE is -0.20%, compared to CAU.AX's ROE of +0.34%. Regarding short-term risk, EXL.AX is more volatile compared to CAU.AX. This indicates potentially higher risk in terms of short-term price fluctuations for EXL.AX.

Stock Price Comparison

Loading...

Frequently Asked Questions